Posts in the “Treatment Options Treatment Options” category:

Bristol Plans Big Lung Cancer Study, Pairing Immunotherapies

Posted by Samantha Powell on March 4th, 2014 |

News Headline: Bristol Plans Big Lung Cancer Study, Pairing Immunotherapies Date: 3/4/14 Outlet Full Name: Reuters Author: Ransdell Pierson http://www.reuters.com/article/2014/03/04/us-bristol-cancer-idUSBREA2328A20140304 (Reuters) – Bristol-Myers Squibb Co on Tuesday said it plans this year to begin a late-stage trial testing whether a combination of two of its high-profile immunotherapies can effectively treat lung cancer, easing concerns about […]

Hormone Therapy Linked to Better Survival After Lung Cancer Diagnosis In Women

Posted by Samantha Powell on February 26th, 2014 |

longchamp sac solde News Headline: Hormone Therapy Linked to Better Survival After Lung Cancer Diagnosis In Women Date: 2/26/14 Outlet Full Name: Medical Xpress Author: No author http://medicalxpress.com/news/2014-02-hormone-therapy-linked-survival-lung.html Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a […]

Lung Cancer Drugs Erlotinib and Gefitinib Under Review by NICE

Posted by Samantha Powell on February 4th, 2014 |

News Headline: Lung Cancer Drugs Erlotinib and Gefitinib Under Review by NICE Date: 2/4/14 Outlet Full Name: Nursing Times Author: No author http://www.nursingtimes.net/nursing-practice/clinical-zones/cancer/nice-to-review-access-to-new-lung-cancer-drugs/5067688.article?blocktitle=News&contentID=4385 The National Institute for Health and Care Excellence is reviewing its guidance on the use of two lung cancer drugs – erlotinib and gefitinib – in response to changing clinical practice. The […]

New Study Raises Questions About Antioxidant Use in Lung Cancer Patients

Posted by Samantha Powell on January 29th, 2014 |

hogan scarpe News Headline: New Study Raises Questions About Antioxidant Use in Lung Cancer Patients Date: 1/29/14 Outlet Full Name: The Washington Post Author: Ariana Eunjung Cha http://www.washingtonpost.com/national/health-science/new-study-raises-questions-about-antioxidant-use-in-lung-cancer-patients/2014/01/29/c37b51a8-88ef-11e3-a5bd-844629433ba3_story.html The supermarket labels touting the benefits of antioxidant-rich foods such as frozen berries and green tea are so ubiquitous that many people assume that taking extra doses […]

Targeted Treatment Better than Chemo in Some Lung Cancers

Posted by Samantha Powell on January 13th, 2014 |

News Headline: Targeted Treatment Better than Chemo in Some Lung Cancers Date: 1/13/14 Outlet Full Name: Drug Discovery & Development Author: No author http://www.dddmag.com/news/2014/01/targeted-treatment-better-chemo-some-lung-cancers Patients with lung cancer who also have a specific gene rearrangement do better on a new targeted therapy compared with standard chemotherapy, according to a study by academics from the Manchester […]

GSK’s Tafinlar Named as FDA Breakthrough Therapy for Lung Cancer

Posted by Samantha Powell on January 13th, 2014 |

News Headline: GSK’s Tafinlar Named as FDA Breakthrough Therapy for Lung Cancer Date: 1/13/14 Outlet Full Name: Reuters Author: Sarah Young http://www.reuters.com/article/2014/01/13/us-gsk-tafinlar-idUSBREA0C0YL20140113 (Reuters) – British pharmaceutical company GlaxoSmithKline said its Tafinlar cancer treatment had been given FDA breakthrough therapy designation for lung cancer, meaning the drug will be fast-tracked within the U.S. regulatory system. GSK […]

Transgene to Move Lung Cancer Drug Into Advanced Tests

Posted by Samantha Powell on January 8th, 2014 |

News Headline: Transgene to Move Lung Cancer Drug Into Advanced Tests Date: 1/8/14 Outlet Full Name: Bloomberg News Author: Albertina Torsoli http://www.bloomberg.com/news/2014-01-08/transgene-to-move-lung-cancer-drug-into-advanced-tests.html Transgene SA (TNG) expects to start enrolling patients for advanced tests of its experimental lung cancer medicine as early as next summer after a mid-stage trial helped determine which people are most likely […]

Research Shows Molecular, Protein Target Therapies May Be Best Treatment for Lung Cancer

Posted by Samantha Powell on January 8th, 2014 |

News Headline: Research Shows Molecular, Protein Target Therapies May Be Best Treatment for Lung Cancer Date: 1/8/14 Outlet Full Name: Red Orbit Author: No author http://www.redorbit.com/news/health/1113041877/research-shows-molecular-protein-targeting-therapies-may-be-best-treatment-for-certain-lung-cancer/ University of Cincinnati (UC) Cancer Institute researchers have found that using therapies specifically targeting the molecular profile of non-small-cell lung cancer with the mutated cancer-causing protein KRas is the […]

Columbus CyberKnife Reports Increased Number of Lung Cancer Treatments

Posted by Samantha Powell on December 19th, 2013 |

News Headline:  Columbus CyberKnife Reports Increased Number of Lung Cancer Treatments Date:  12/19/13 Outlet Full Name:  PR Web Author:  No author http://www.prweb.com/releases/2013/12/prweb11438355.htm Columbus CyberKnife has treated more than 70 lung cancer cases this year with increased volume last quarter. The center has drawn patients from around the region seeking a noninvasive alternative to traditional lung […]

Older Lung Cancer Patients Desire Information on Complementary Therapies

Posted by Samantha Powell on November 26th, 2013 |

News Headline: Older Lung Cancer Patients Desire Information on Complementary Therapies Date:  11/26/13 Outlet Full Name: About.com – Lung Cancer Author: Lynne Eldridge http://lungcancer.about.com/b/2013/11/26/older-lung-cancer-patients-desire-information-on-complementary-therapies.htm Once considered “alternative” treatments, many cancer centers are now using complementary therapies as a regular part of cancer treatment. This integrative approach – combining conventional treatments such as chemotherapy and surgery with complementary […]